Search Results - "Schüssler, S."

Refine Results
  1. 1

    A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex by Mammadova, D, Vecko, J, Hofmann, M, Schüssler, S. C, Deiters, L, Canda, A, Wieland, A. K, Gollwitzer, S, Hamer, H, Trollmann, Regina

    Published in Orphanet journal of rare diseases (09-11-2023)
    “…Abstract Background Tuberous sclerosis complex (TSC) is a rare multisystem disorder caused by mutations in the TSC1 or TSC2 gene. More than 90% of patients…”
    Get full text
    Journal Article
  2. 2

    Long-term outcomes of very-low-birth-weight and low-birth-weight preterm newborns with neonatal seizures: A single-center perspective by Schüssler, S.C., Schmidt, M., Deiters, L., Candova, A., Fahlbusch, F.B., Trollmann, R.

    Published in European journal of paediatric neurology (01-01-2022)
    “…Newborn seizures are frequent in preterm newborns and indicate brain lesions in many cases. The objective of this observational study was to investigate the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Comparison of care dependency and related nursing care problems between Austrian nursing home residents with and without dementia by Schüssler, S, Dassen, T, Lohrmann, C

    Published in European geriatric medicine (01-02-2015)
    “…Abstract Objective Demographic developments have led to increased chronic diseases, such as dementia, which result in care dependency and nursing care problems…”
    Get full text
    Journal Article
  5. 5

    Binding characteristics of [ 3 H]‐JSM10292: a new cell membrane‐permeant non‐peptide bradykinin B 2 receptor antagonist by Faussner, A, Schüssler, S, Feierler, J, Bermudez, M, Pfeifer, J, Schnatbaum, K, Tradler, T, Jochum, M, Wolber, G, Gibson, C

    Published in British journal of pharmacology (01-10-2012)
    “…BACKGROUND AND PURPOSE A 3 H‐labelled derivative of the novel small‐molecule bradykinin (BK) B 2 receptor antagonist JSM10292 was used to directly study its…”
    Get full text
    Journal Article
  6. 6

    Rare intronic mutation between Exon 62 and 63 (c.9225–285A>G) of the dystrophin gene associated with atypical BMD phenotype by Schüssler, SC, Gerhalter, T, Abicht, A, Müller-Felber, W, Nagel, AM, Trollmann, R

    Published in Neuromuscular disorders : NMD (01-08-2020)
    “…•Rare intronic mutation of the DMD gene associated with atypical BMD phenotype.•Assessment of qualitative changes in skeletal muscle by 23Na-MRI.•Disturbed…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Controlled Release of Vanadium from a Composite Scaffold Stimulates Mesenchymal Stem Cell Osteochondrogenesis by Schussler, S. D., Uske, K., Marwah, P., Kemp, F. W., Bogden, J. D., Lin, S. S., Livingston Arinzeh, Treena

    Published in The AAPS journal (01-07-2017)
    “…Large bone defects often require the use of autograft, allograft, or synthetic bone graft augmentation; however, these treatments can result in delayed osseous…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Binding characteristics of [3H]‐JSM10292: a new cell membrane‐permeant non‐peptide bradykinin B2 receptor antagonist by Faussner, A, Schüssler, S, Feierler, J, Bermudez, M, Pfeifer, J, Schnatbaum, K, Tradler, T, Jochum, M, Wolber, G, Gibson, C

    Published in British journal of pharmacology (01-10-2012)
    “…BACKGROUND AND PURPOSE A 3H‐labelled derivative of the novel small‐molecule bradykinin (BK) B2 receptor antagonist JSM10292 was used to directly study its…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    1815PRandomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references by Velinova, M, Bellon, A, Nakov, R, Schussler, S, Schier-Mumzhiu, S, Schelcher, C, Koch, S D, Skerjanec, A, Wang, J, Krendyukov, A, Otto, G P

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background The pharmacokinetic (PK)/pharmacodynamic (PD), safety and immunogenicity profiles of Sandoz biosimilar pegfilgrastim (Ziextenzo®) and EU…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Mangelernährung in österreichischen Pflegeeinrichtungen by Mandl, M, Schönherr, S, Schüssler, S, Lohrmann, Ch

    “…Mangelernährung, Sturz und Dekubitus zählen zu den häufigen Pflegeproblemen in der Praxis. In der Literatur wird beschrieben, dass bis zu 85 Prozent der…”
    Get full text
    Journal Article